MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
MIMEDX (Nasdaq: MDXG) announced that senior management will participate in the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026, in Minneapolis, MN.
Rhea-AI Summary
MIMEDX (Nasdaq: MDXG) announced that senior management will participate in the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026, in Minneapolis, MN.
Interested investors are invited to request meetings with management through their Craig-Hallum representative.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MDXG
In the May 21 session, MDXG declined 4.75%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference edition
- 23rd annual
- Craig-Hallum Institutional Investor Conference mentioned in the article
Historical Context
-
Commercial launch of G4Derm Plus with exclusive U.S. distribution rights.
-
Q1 2026 sales decline, major Wound segment drop, guidance reduced.
-
Announcement of timing and access details for Q1 2026 results call.
-
Cost reduction initiative targeting $40M in annual savings and role changes.
-
Sponsorship and presentations at leading advanced wound care conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026 in Minneapolis, MN. Investors interested in meeting with senior management may contact their Craig-Hallum representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.